Alterity Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $802 | $802 | $2,118 | $1,059 |
Gross Profit | 771 | 771 | 2,044 | 1,000 |
EBITDA | -3,762 | -3,762 | -14,615 | -6,483 |
EBIT | -3,771 | -3,771 | -14,688 | -6,492 |
Net Income | -3,586 | -3,586 | -12,616 | -6,308 |
Net Change In Cash | 802 | 802 | 2,118 | 1,059 |
Free Cash Flow | -4,179 | -4,179 | -8,110 | -2,577 |
Cash | 4,536 | 4,536 | 12,638 | 12,638 |
Basic Shares | 5,313,423 | 5,313,423 | 6,308,140 | 4,794,472 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $4,019 | $3,916 | $5,123 | $4,339 |
Gross Profit | 3,804 | 3,631 | 4,758 | 3,979 |
EBITDA | -19,571 | -17,514 | -17,392 | -19,360 |
EBIT | -19,719 | -17,616 | -17,446 | -19,435 |
Net Income | -19,123 | -13,806 | -12,847 | -15,309 |
Net Change In Cash | 4,019 | 3,916 | 5,123 | 4,339 |
Free Cash Flow | -12,611 | -20,043 | -12,426 | -17,340 |
Cash | 12,638 | 15,773 | 34,806 | 28,115 |
Basic Shares | 3,648,875 | 2,427,841 | 2,405,990 | 1,696,876 |
Earnings Calls
| Quarter | EPS |
|---|---|
2023-03-31 | $0 |
2022-12-31 | $0 |
2022-09-30 | $0 |
2022-06-30 | -$0.23 |
